{"name":"Ensem Therapeutics","slug":"ensem-therapeutics","ticker":"","exchange":"","domain":"ensem.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPZTE2anY3M0ctRFpUSG1hV21zaUhUaTdNdENYY2VnTmRWYl84N1JsSjlSaEdQZm0wOUpLdV9IRFlQUDhtTjc5b2tWaWl6anh2UmlZdGREWGZXNUcwS3oxLVI5aUNFVVNhS043RW05bXBodXRtblUxWVlGZEN3YUhJLWZVTDZxTXVYQmQ1MVBGcmM0bjl3a2pUYmpJS1dQQjV0enJqVHFCWG1XQUxhQlZTUGJaeGQ3WXdlYTZkMXpKNzJnOTcxUld4Uk9zS19udm1vUVRF?oc=5","date":"2026-02-02","type":"trial","source":"businesswire.com","summary":"Ensem Therapeutics Doses First Patient in China in ETX-636 Global Phase 1/2 Study - businesswire.com","headline":"Ensem Therapeutics Doses First Patient in China in ETX-636 Global Phase 1/2 Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQQWF4bjBGZURZNXMyM2dVMGl2eURNclVlcUFjbFpxXy1TLV9mb0Myc1lhTFlUVG9lSm1YaEd5bkFSN3dReGtLRkFGaHdWQ3EtQWNYTzJOTnNOSFlSTVE2UVF4LXNab0s2V1ZtVzl4WHBpN2ctY0lQVGhBQUFCb1JtM1IySjFmaDlLQ2ZCYVhfQms5RTIzVXo2RXA4R2plVF9mYlBF?oc=5","date":"2025-11-04","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in October 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in October 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxPbGRkcWkzdG1PU2x3SmpMZzY1NExHVmdDbElHTHEyZ3pKNl84T1FYZ1JDZ2hMdm1IZ2FjYV82cm9QM3dLOGpPcnFEVUtvd3h5aXo3SXhRVnRNb3FkWkRRUHlwMnBSc0llV2RNRzd1cFVlb1lfQTZnazl3MUhOd1J5aElHak9GbDBaMW5aZ3RWMWs4c25Yd19xY3lCTEFOZ05JSzhISFdoQUFhVElqdzAtTmJFNGUwZHZkUFVaTlpNT25Qa3FEZWtjV0hhSXhYOWYwYTNZdEpYV2EzMTJPRDQyeW1PTGJfTEI1UnRjNkYtZ0VjRDg5ZFIyLVcxT1JESFdFNms0d0FPRmJXRElhWVFIdWFZRS1KWDdoQXQzY1N5eUpqSWc?oc=5","date":"2024-06-12","type":"trial","source":"businesswire.com","summary":"Ensem Therapeutics Announces Achievement of Milestone Following Entry of Small Molecule CDK2 Inhibitor into Clinical Trials for Solid Tumors - businesswire.com","headline":"Ensem Therapeutics Announces Achievement of Milestone Following Entry of Small Molecule CDK2 Inhibitor into Clinical Tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOSFpKcU9ieEdnSGhqM0FPQnZiWk1YS3oweS1xUmxFNE9oV1gzYWtIX0RlLU9WYUYtUWRyQUh1WS1reUQ0S1p2bGJSQktYdDYzME1rWHdZdkEtLThSV01uZGdtbUx3eUdRQl9EZ09ENzgwQmpYbzZpa2tZQm9iYTJCeDI0ZEFaRTliYzMweXQ0SndIampYU1UxcFlaZ1hhSTVJUlRHdjB3?oc=5","date":"2023-12-01","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—AstraZeneca's KRAS bet; BeiGene's cancer deal; Coherus' PD-1 price - Fierce Pharma","headline":"Fierce Pharma Asia—AstraZeneca's KRAS bet; BeiGene's cancer deal; Coherus' PD-1 price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxONzJ5X2RURDhHOVZhMGwyenJrdGh4YkNnbXdPWjFFcUYzX0JGamxSMHdtSWM2NTdWeGRaN1M0djZUWHNma3dmTVJBTU1sR05CVFRlN20td1lTbnQ3OG1ncTVzTG9FdWJSVnhkcndaTGhOcTFRS054YnNkVUZSWi16dHVla3NlWlZYbU5Vc251SndSVTM0Z3EtV0NDMWNRVGpFdjhDTGhQSU1zaWJmV1lV?oc=5","date":"2023-11-21","type":"deal","source":"Pharmaceutical Technology","summary":"BeiGene strikes deal worth $1.3bn with Ensem for CDK2 inhibitor - Pharmaceutical Technology","headline":"BeiGene strikes deal worth $1.3bn with Ensem for CDK2 inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNRmdZTmRCM2EtVFAxaUlqanp2WjhJamtaclo2NWQ0WUV4YTliWm8wMGMxeUVFaEVDRGtFWTRzWkZ3Y1ZzMjdMenJUc0txZVM2SzdGTTg2WThIbFhUejNCaDVWX2lvT3BNMzRHRHdNLTFpckN5QXlDYjdIY3dJSmluRXlRc2RwdXlWTUktYTJnY3FVdlBlczhwbDgycFFWN0hGa0poel9HMXd3bUVoWWpwR19oTW9xY3ZzbzZrRGlWWG5wck1IaG9yYm41RjVMeml0TEpENE9zQlljUjBsUFU0WnRsSQ?oc=5","date":"2023-11-21","type":"deal","source":"businesswire.com","summary":"BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 Inhibitor - businesswire.com","headline":"BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 Inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOdnRiOGlZMlBtU2RrOVhCWFlSUzhHM3ZBM21neFBtbktZZFBmT01YSFNJSFZVVzJvV3ZjVnF2bWhZNVBvRHpDLXFBZ2wxdGhrTm1LMkthTTZkcFJyMDlOd0RNV19td19lQUVjTlNPVXJyeUwzWTJHeUZNd2dONTMxSVZteThJbTlFeW9Fd2g3QQ?oc=5","date":"2023-06-06","type":"deal","source":"Medical Buyer","summary":"Ensem Therapeutics, Singapore names Dr Shengfang Jin as CEO - Medical Buyer","headline":"Ensem Therapeutics, Singapore names Dr Shengfang Jin as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxObVpxS3JFRHNHZUVZREhDUGVVRTg1ZGtha1JPaWloM0VQdDlZcVc0bGxXd1pkR1VkYVpJMDZHRkdGTkVUR3g5QnVuME9UMTdTcENidTFvLXF4Y0xUODJ1bHRiWWFrcnBoRHI5T210VmFYOFIxSElKRk1QU1JHUldrUE9md2hEMF9PclBrVFZsWDBEclJWeHhBWHRUa3luSG1EaEV5WmdsQWI0TkdiV0Q5QVhmeFVrTUNhd05SZ1dIVm1PTHNGdXhUVzBPTlF3Q1VZaTBJOTBrUzBmMkZv?oc=5","date":"2023-06-05","type":"pipeline","source":"prnewswire.com","summary":"ENSEM Announces the Promotion of Shengfang Jin, PhD to President & Chief Executive Officer - prnewswire.com","headline":"ENSEM Announces the Promotion of Shengfang Jin, PhD to President & Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQRHkzV3pEU0dHemZhQ1pUSTBKeW93WXBOaThoMGpMSE03eTVHZ2hRc0FjNmg1cmJwZzhXc0tDc2ZuR2hxVmZEa3VUb2RlN3JpcjFWbTRtLUxkNUNlNVMwUmZxT3BHTUlhblo1ZjNfWGdhTm0zakU3MHItN2NjNG9KN3RRVlFGZ0hzNWRQd1ZhcEZTTVBXNWtpdkNocUk5UUw4?oc=5","date":"2022-04-07","type":"pipeline","source":"BioSpace","summary":"ENSEM Therapeutics Banks $67 Million in Search of New Drug Targets - BioSpace","headline":"ENSEM Therapeutics Banks $67 Million in Search of New Drug Targets","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}